✦ LIBER ✦

BCR-ABL1 Kinase Domain Mutation Analysis in an Irish Cohort of Chronic Myeloid Leukemia Patients

✍ Scribed by McCarron, Sarah L.; O'Connor, Lisa M.; Langabeer, Stephen E.; Conneally, Eibhlin

Book ID: 120004928
Publisher: Mary Ann Liebert
Year: 2013
Tongue: English
Weight: 96 KB
Volume: 17
Category: Article
ISSN: 1945-0265
DOI: 10.1089/gtmb.2012.0272

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Characteristics of BCR–ABL kinase domain

Characteristics of BCR–ABL kinase domain point mutations in Chinese imatinib-resistant chronic myeloid leukemia patients

✍ YaZhen Qin; ShanShan Chen; Bin Jiang; Qian Jiang; Hao Jiang; JinLan Li; LingDi L 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 116 KB

An Intron-Derived Insertion/Truncation M

An Intron-Derived Insertion/Truncation Mutation in the BCR-ABL Kinase Domain in Chronic Myeloid Leukemia Patients Undergoing Kinase Inhibitor Therapy

✍ Laudadio, Jennifer; Deininger, Michael W.N.; Mauro, Michael J.; Druker, Brian J. 📂 Article 📅 2008 🏛 American Society for Investigative Pathology 🌐 English ⚖ 520 KB

ABL Kinase Domain Mutations in Patients

ABL Kinase Domain Mutations in Patients with Chronic Myeloid Leukemia in Jordan

✍ Awidi, Abdalla; Ababneh, Nidaa; Magablah, Ahmad; Bsoul, Nazzal; Mefleh, Razan; M 📂 Article 📅 2012 🏛 Mary Ann Liebert 🌐 English ⚖ 108 KB

Analysis of BCR–ABL1 tyrosine kinase dom

Analysis of BCR–ABL1 tyrosine kinase domain mutational spectra in primitive chronic myeloid leukemia cells suggests a unique mutator phenotype

✍ Grant, H; Jiang, X; Stebbing, J; Foroni, L; Craddock, C; Griffiths, M; Clark, R 📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 English ⚖ 457 KB

BCR-ABL kinase domain mutations in tyros

BCR-ABL kinase domain mutations in tyrosine kinase inhibitors-naïve and -exposed Southeast Asian chronic myeloid leukemia patients

✍ Wanwisa Wongboonma; Wanna Thongnoppakhun; Chirayu U. Auewarakul 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 558 KB

BCR-ABL kinase domain mutation analysis

BCR-ABL kinase domain mutation analysis in chronic myeloid leukemia patients treated with tyrosine kinase inhibitors: recommendations from an expert panel on behalf of European LeukemiaNet

✍ Soverini, S.; Hochhaus, A.; Nicolini, F. E.; Gruber, F.; Lange, T.; Saglio, G.; 📂 Article 📅 2011 🏛 American Society of Hematology 🌐 English ⚖ 504 KB